Kamada Ltd. (KMDA)
Nasdaq: KMDA · Pharmaceutical Preparations · Rehovot, IL · filing with the SEC since 2013
Who owns Kamada Ltd.
As filed with the SECHolders of 5% or more
2
Leon Recanati holds 6.07% of Ordinary Shares, par value NIS 1.0 per share, as its SCHEDULE 13G/A filed Mar 5, 2025 says.
Directors and officers
20
report now, of 20 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Leon Recanati
SCHEDULE 13G/A · filed Mar 5, 2025 · Ordinary Shares, par value NIS 1.0 per share
Recanati Leon
SCHEDULE 13G/A · filed Mar 16, 2026 · Ordinary Shares, par value NIS 1.0 per share
Phoenix Financial Ltd.
SCHEDULE 13G/A · filed Aug 20, 2026 · Ordinary Shares, par value NIS 1.00 each · reported falling below 5%, from n/a in Jun 5, 2025
What KMDA reports owning in othersstakes of 5% or more, and other ties
5 subsidiaries in 3 countries, from the list filed with the 20-F filed Mar 11, 2026.
Insider tradesForm 4
4sales
0purchases
0sales on a scheduled plan
1people selling
$1.7Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 20 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Tsur David | director | 4 | $1.7M | 0 | 0 | $0 |